April 16, 2015 | The Trendlines Group portfolio company Leviticus Cardio announced that it raised over $1.5 million from private investors. The company will reportedly use the funds to commence its “first-in-man” feasibility study with the unique Coplanar Energy System. Leviticus Cardio is a medical device company founded in 2008 dedicated to improve the clinical outcome for patients implanted with a left ventricular assist device (LVAD) for impaired cardiac function.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Tel Aviv University Ranked 7th In World For Global Entrepreneurship
October 01, 2024
IIA Backs R&D By Startup Using Bacteria To Help Crops Grow
September 30, 2024
GreenTech Startup Receives €5M European Sustainability Grant
September 30, 2024
Facebook comments